Meaningful Metrics for the Microbiology Laboratory
Posted on May 7, 2021
Karen Zink McCullough, Principal Consultant, MMI Associates
Background In a February 2013 Federal Register notice, the United States Food and Drug Administration (FDA) described a plan for the mitigation of drug shortages and asked for public comment on that plan1. As part of that initiative, the Agency proposed the following: II.1.a, “To assist in the eva...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy















